Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Novartis
Pharmaceuticals
Bristol Myers Squibb
AstraZeneca
GSK
Johnson and Johnson
Pfizer
Sanofi
Topics

Advertisement

Advertisement

Novartis

Share

Top Latest Popular

In the last hour

European shares dip as higher crude revives inflation worries; Novartis drags Business Recorder, Pakistan 08:33

STAT Plus: Neuromuscular drug from Novartis fails in key study, adding to pressure on company STAT 08:32

In the last 4 hours

Novartis enters into exclusive promotion and distribution agreement with Novartis Healthcare The Business Standard 06:12

Advertisement

Advertisement

Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1) Novartis (Press Release) 06:09

Yesterday

Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock Down Zacks 17:53 Mon, 07 Sep

European shares subdued as surging crude sharpens focus on ECB rate path The Economic Times 17:52 Mon, 07 Sep

Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal Zacks 17:33 Mon, 07 Sep

360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 cr The Economic Times 16:51 Mon, 07 Sep

Novartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for ₹1,250 crore The Hindu Business Line 14:46 Mon, 07 Sep

Novartis India buys Minipress brands from Pfizer for ₹1,250 crore The Business Standard 13:10 Mon, 07 Sep

Novartis hit as Lp(a) drug fails cardio outcomes trial pharmaphorum 12:26 Mon, 07 Sep

Novartis’ pelacarsen fails to meet primary endpoint in Lp(a)HORIZON trial Clinical Trials Arena 10:38 Mon, 07 Sep

Novartis stock falls nearly 4% as heart-drug failure deepens setbacks The Straits Times 10:34 Mon, 07 Sep

Global Market: European stocks subdued as oil surge fuels inflation, ECB rate hike bets The Economic Times 10:04 Mon, 07 Sep

Advertisement

European shares dip as rise in oil prices weighs; Novartis slips Business Recorder, Pakistan 09:07 Mon, 07 Sep

Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore The Hindu Business Line 08:50 Mon, 07 Sep

Novartis India to acquire Pfizer's 'Minipress' trademark for Rs 1,250 crore The Times of India 08:47 Mon, 07 Sep

Novartis Korea partners with Yuhan to expand Rhapsido reach in chronic urticaria Korea Biomedical Review 06:47 Mon, 07 Sep

Sunday

Novartis India eyes therapy-aligned acquisition, Tier 2-3 market push The Business Standard 06:46 Sun, 06 Sep

Novartis India to pursue therapy-aligned acquisitions; eyes expansion in Tier 2 and Tier 3 markets The Times of India 06:23 Sun, 06 Sep

Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines BioPharma Dive 01:38 Sun, 06 Sep

Friday

Novartis’s Lp(a) Inhibitor Pelacarsen Fails Phase III Cardiovascular Outcomes Trial Scrip Pharma Intelligence 23:39 Fri, 04 Sep

Novartis Drug Fails Key Test of New Approach to Heart Disease Bloomberg Law 22:27 Fri, 04 Sep

STAT Plus: Novartis’ experimental cardiovascular drug fails a pivotal study STAT 22:10 Fri, 04 Sep

Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) Novartis (Press Release) 21:45 Fri, 04 Sep

Ionis partner Novartis announces Lp(a)horizon Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD) Business Wire (Press Release) 21:42 Fri, 04 Sep

Novartis strikes $3.2 billion deal with Alteogen as drug delivery patent licences pile up IAM 14:18 Fri, 04 Sep

RBC backs Oxford BioMedica with 'outperform' rating amid Novartis trial halt Proactive Investors (UK) 10:06 Fri, 04 Sep

Thursday

Developers Pause Clinical Trials of 2 CAR T-Cell Therapies in MG, MS, and Other Conditions Rare Disease Advisor 17:56 Thu, 03 Sep

Novartis announces trial results for remibrutinib in relapsing multiple sclerosis PMLiVE 13:45 Thu, 03 Sep

Novartis signs deal with Alteogen for drug delivery Pharmaceutical Business Review 10:29 Thu, 03 Sep

Novartis signs drug delivery deal with Alteogen Pharmaceutical Technology 10:20 Thu, 03 Sep

Novartis deal caps Alteogen’s banner year as ALT-B4 moves into commercial era Korea Biomedical Review 03:21 Thu, 03 Sep

Wednesday

Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies Zacks 20:31 Wed, 02 Sep

Novartis taps Alteogen’s Alt-B4 for SC drug delivery in $3B deal BioWorld 20:31 Wed, 02 Sep

Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts BioPharma Dive 18:27 Wed, 02 Sep

Novartis Signs Up To $3.2B Hybrozyme Deal With Alteogen RTT News 16:55 Wed, 02 Sep

Novartis signs up to $3.2bn Alteogen deal for subcutaneous drug delivery Manufacturing Chemist 16:10 Wed, 02 Sep

Novartis to cut up to 130 jobs in Basel Swiss Info 16:02 Wed, 02 Sep

Panmure Liberum says OxfordBiomedica share fall overdone after Novartis and BMS pause trials Proactive Investors (US) 13:05 Wed, 02 Sep

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis